Coronavirus pneumonia. Conceptual computer illustration showing coronavirus in human lungs. Different strains of coronavirus are responsible for diseases such as the common cold, gastroenteritis and SARS (severe acute respiratory syndrome). A new coronavirus (SARS-CoV-2) emerged in Wuhan, China, in December 2019. The virus causes a mild respiratory illness (Covid-19) that can develop into pneumonia and be fatal in some cases. The coronaviruses take their name from their crown (corona) of surface proteins, which are used to attach and penetrate their host cells. Once inside the cells, the particles use the cells' machinery to make more copies of the virus.

Our respiratory panel can detect twenty-three microbes responsible for a myriad of respiratory infections

Many respiratory illness are caused by viruses, which are easily detected and identified by PCR, but not by traditional techniques.   With a focus on cutting unnecessary antibiotic usage, the respiratory panel can aid the clinician in determining a better course of action regarding drug treatment.

  • With faster turnaround times and higher sensitivity than traditional methods, molecular panels allow for rapid treatment specific to the organism of concern while also identifying a pathogen earlier in the course of infection
  • Molecular techniques are the only methods able to accurately detect each variant of COVID-19. While not a part of the standard respiratory panel, COVID-19 can be ordered with any respiratory panel for a more complete assessment of the patient’s condition.
While not included on the full panel, Legionella and Pertussis can be made available in combination with the respiratory panel for specific cases.

Contact us here to learn more about how our respiratory pathogen panels can benefit your patients.